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One function of glucocorticoids is to restore homeostasis after an acute stress response
by providing negative feedback to stress circuits in the brain. Loss of this negative
feedback leads to elevated physiological stress and may contribute to depression, anxiety,
and post-traumatic stress disorder. We investigated the early, developmental effects of
glucocorticoid signaling deficits on stress physiology and related behaviors using a mutant
zebrafish, grs357, with non-functional glucocorticoid receptors (GRs). These mutants are
morphologically inconspicuous and adult-viable. A previous study of adult grs357 mutants
showed loss of glucocorticoid-mediated negative feedback and elevated physiological and
behavioral stress markers. Already at 5 days post-fertilization, mutant larvae had elevated
whole body cortisol, increased expression of pro-opiomelanocortin (POMC), the precursor
of adrenocorticotropic hormone (ACTH), and failed to show normal suppression of
stress markers after dexamethasone treatment. Mutant larvae had larger auditory-evoked
startle responses compared to wildtype sibling controls (grwt ), despite having lower
spontaneous activity levels. Fluoxetine (Prozac) treatment in mutants decreased startle
responding and increased spontaneous activity, making them behaviorally similar to
wildtype. This result mirrors known effects of selective serotonin reuptake inhibitors
(SSRIs) in modifying glucocorticoid signaling and alleviating stress disorders in human
patients. Our results suggest that larval grs357 zebrafish can be used to study behavioral,
physiological, and molecular aspects of stress disorders. Most importantly, interactions
between glucocorticoid and serotonin signaling appear to be highly conserved among
vertebrates, suggesting deep homologies at the neural circuit level and opening up new
avenues for research into psychiatric conditions.
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INTRODUCTION
Glucocorticoids serve a homeostatic function in acute stress
responses by providing negative feedback to brain stress cir-
cuits. Activated glucocorticoid receptors (GRs) bind to DNA and
regulate the transcription of many genes, including (but not
restricted to) components of the hypothalamo-pituitary-adrenal
axis. Combined, these expression changes effectively terminate
the stress response (Figure 1), but they also have a plethora of
other effects on behavior and physiology.
Several neural mechanisms may underlie stress effects on
mood and behavior (Howell et al., 2011). Cortisol and
Corticotropin Releasing Hormone (CRH) acutely modify limbic
system and prefrontal cortex neurons involved in regulation of
affect (Meng et al., 2011). Repeated stress may induce long-term
neural adaptations, including down regulation of GR expression
(Howell et al., 2011), which has been linked to depressive behav-
iors in rodent models (Zouh et al., 2011). Excessive cortisol in
early life can permanently suppress the GR gene by epigenetic
modification, leading to elevated stress in adulthood (Wilkinson
and Goodyer, 2011).
Stress also contributes to serotonin dysregulation, a hallmark
of depression (Anacker et al., 2011). CRH activates a subpopula-
tion of serotonergic neurons in the raphe nuclei, and recruitment
of this pathway mediates anxiety-like behavior in rats (Meloni
et al., 2008). Chronic stress decreases serotonin receptor expres-
sion (Kieran et al., 2010) and serotonin binding in the limbic
system and cortex, and lowers behavioral responses to sero-
tonin (Bush et al., 2003). Serotonin also influences hypothalamic
stress pathways (Locatelli et al., 2010). Selective serotonin reup-
take inhibitors (SSRIs) increase GR expression (Erdeljan et al.,
2001), potentially compensating for stress-induced downregu-
lation, and they normalize stress-induced behavioral deficits in
animal models (Leventopoulos et al., 2009).
Zebrafish are a promising model for studying human stress-
related disorders because of homologies in key genetic, physio-
logical, and behavioral features of stress regulation (Egan et al.,
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FIGURE 1 | A simplified schematic of the vertebrate HPA stress
pathway in normal and grs357 mutant zebrafish in which the
glucocorticoid receptor is non-functional. Lines with arrowheads
indicate feed forward excitation and lines with blocked heads indicate
feedback inhibition. Regular font signifies neural structures and italicized
font signifies diffusible signaling molecules. Glucocorticoid feedback from
the periphery to the brain normally inhibits further brain stress activity by
transcriptional suppression of genes including those encoding CRH and
ACTH (left, solid lines). In grs357 mutant zebrafish, the glucocorticoid
receptor is non-functional, preventing negative feedback (right, dashed line),
and leading to prolonged release and higher levels of stress intermediaries
(bold font). Abbreviations: CRH, Corticotropin releasing hormone; ACTH,
Adrenocorticotropic hormone; HPA, Hypothalamic-pituitary-adrenal axis;
PVN, Paraventricular nucleus.
2009; Schaaf et al., 2009; Löhr and Hammerschmidt, 2011; Piato
et al., 2011; Ziv et al., 2012). Zebrafish show mature physiolog-
ical stress reactivity, including GR-mediated negative feedback,
by 4 dpf (Alderman and Bernier, 2009; Alsop and Vijayan, 2009;
Machluf et al., 2011), allowing stress dynamics to be studied in the
experimentally tractable fish larvae. Their small size and aquatic
environment allow the monitoring of single-animal behavioral in
microtiter format (96-well plates, or similar), a feature that makes
them attractive for high-throughput whole-animal in vivo screens
of small compound libraries (Rihel et al., 2010).
We investigated stress behavior and physiology in mutant
zebrafish larvae with dysfunctional GRs (grs357). A previous study
showed that the s357 mutation is a single nucleotide substitu-
tion at position 443, a region essential for DNA binding. The
mutant GR can bind cortisol and translocate to the nucleus,
but shows no transcriptional activity (Ziv et al., 2012). The
mutant was identified on the basis of impaired visual back-
ground adaptation (VBA; Muto et al., 2005), a GR-dependent
neuroendocrine response that causes skin pigment cells to con-
tract under bright illumination (Kramer et al., 2001). grs357 larvae
appear darker than grwt in the VBA assay (Figure 2) showed
reduced swimming activity (Muto et al., 2005). grs357 mutants
are viable, but adults show elevated behavioral and physiolog-
ical stress responses. Upon transfer to a novel tank, which is a
mild stressor, adult mutants show a longer duration immobiliza-
tion response, reduced exploration, and they do not habituate
FIGURE 2 | Representative photographs of a VBA+ (left) and VBA−
(right) larva from the same clutch after exposure to the VBA stimulus
on day 5 post-fertilization. The dark fish were reproducibly genotyped and
shown to be homozygous grs357 mutants. Non-dark siblings were either
homozygous wildtype or heterozygotes. Scale bar = 1mm.
after repeated novel tank exposure trials. Fluoxetine or expo-
sure to other zebrafish normalizes these responses in mutants,
strengthening the conclusion that the GR mutation results in a
depression-like phenotype (Ziv et al., 2012).
Here we demonstrate that GR-mediated gene regulation and
stress reactivity are measurably altered in grs357 mutant larvae
already shortly after hatching, when they begin to swim and
search for food. Addition of the SSRI fluoxetine to the tank water
was able to modify these parameters in both mutants and wild-
type larvae. These findings show a contribution of the serotonin
signaling system to naïve (unconditioned) stress response and
extend the phylogenetic conservation of stress mechanisms to
brain circuitry and behavior.
MATERIALS AND METHODS
ANIMALS
Adult grs357 zebrafish were generated andmaintained as described
(Muto et al., 2005). Adult breeding pairs were confirmed het-
erozygous grs357 mutant carriers by genotyping of fin clip samples
(∗), and by the distribution of VBA—phenotype in larval clutches.
Adults and larvae were housed according to standard labora-
tory conditions (Matthews et al., 2002). A 14/10 light/dark cycle
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was maintained to entrain circadian rhythms. All larvae used in
behavioral experiments were siblings from the same parents. All
procedures were approved by an IACUC review committees at
Humboldt State University and the University of California, San
Francisco, CA.
SORTING grs357 MUTANTS BY VBA
Clutches were run in the VBA assay on day 5 or 6 post-fertilization
to sort mutants from wildtype larvae prior to experimentation.
Larvae were placed in 60mm plastic petri dishes, up to 40 per
dish, in standard zebrafish water, and exposed to 20min darkness
by placement in an opaque plastic box, and were then transferred
onto a white background under bright, whole-field illumination
(using a 30W fluorescent lamp mounted 18 inches above the
dish). These conditions reliably trigger VBA responses in normal
zebrafish larvae (Muto et al., 2005;Hatamoto andShingyoji, 2008).
DRUG TREATMENTS
Larvae treated with fluoxetine hydrochloride (Sigma) were incu-
bated in a 4.6μM fluoxetine solution for the 24 h immediately
prior to behavioral testing (starting on day 5 post-fertilization).
Fluoxetine was dissolved in regular larval water and pH’d to 7.2.
This concentration and timing of exposure was selected on the
basis of a previously published study (Airhart et al., 2007). After
incubation larvae were transferred using a 2ml plastic pipette
from fluoxetine into a 60mm rinse dish containing regular egg
water, and immediately transferred again into behavior record-
ing wells containing regular egg water. Control larvae received
equal number and timing of transfers but were not exposed to
fluoxetine. Larvae treated with betamethasone 17-valerate (a syn-
thetic steroid and cortisol analog; Sigma) were incubated in a
25 or 30 uM solution for 24 h prior to euthanizing and processing
for in situ hybridization (ISH). Betamethasone was dissolved in
100% ethanol to make a 1000× stock solution, and then diluted
in regular egg water for bath application to larvae. Control lar-
vae were incubated in the same ethanol concentration without
Betamethasone added.
BEHAVIORAL ASSAYS
Larval behavior was recorded with digital video cameras (Pixelink
PLA-740 for spontaneous activity recordings, PhotonFocusMV1-
1312 for startle swims) and images were stored on a computer
for offline analysis. The behavior apparatus was housed inside a
sound-attenuating cabinet. Infrared (IR) illumination was used
for image capture and the recording area was maintained in dark-
ness. Larvae were individually transferred using a 2ml plastic
pipette into wells (7mm diameter) of a clear plastic 24 well tissue
culture plate (Fisher Scientific) containing 1ml of larval medium
per well. The plate was positioned on a glass shelf and a white,
light diffusing plastic sheet was placed on top of it. The IR illu-
minator (Raytec Systems Inc) was positioned above the plate,
and cameras below, providing high-contrast, shadow-free images.
Up to 4 plates (96 larvae) were recorded simultaneously. A com-
puter controlled image acquisition and presentation of sensory
stimuli through a USB input-output board (Labjack U-12) run
by a control program written specifically for each experiment.
Temperature in the recording area was automatically logged at
10min intervals and maintained at 27 ± 2◦C.
The spontaneous activity assay was run at 5–6 dpf, imme-
diately after VBA sorting of mutants. Activity was recorded in
darkness to remove visually mediated effects and allow assess-
ment of circadian entrainment. Images were acquired at a rate
of 0.5Hz for 24 h, beginning at zeitgeber time (ZT) 20 h. Two
spontaneous activity experiments were conducted using separate
clutches. The first compared activity level and circadian rhythm
in grs357 mutants and controls (N = 48 per group) across a 24 h
recording period. In the second experiment, half of the larvae in
each genotype group (N = 24 per group) were treated with fluox-
etine (4.6μM for 24 h prior to testing) and activity was recorded
for 8 h (from CT 13–21 h). Automated computer analysis of the
images determined whether a larva had moved from one video
frame to the next (a 2 s interval) for each well across the entire
video. There were 1800 video frames per hour, and results were
expressed as the percentage of time the larva was in motion per
hour (number of frames with movements/1800).
Auditory startle was evoked using a mechanical tapping that
produced approximately 75 decibels at the recording plate. This
stimulus reliably produced a “startle response” consisting of a
C-bend within 200ms followed by a <1 s bout of rapid swim-
ming. Movement was video recorded at 100 frames per second
for 1 s following the tap. Swimming distance and group response
rate were analyzed on each trial. One block of trials consisted
of five consecutive tap trials with 2 s between taps (10 s total).
Five consecutive trial blocks were presented, with 30min between
blocks, resulting in 25 trials total over 150min. Four groups
of larvae were tested simultaneously: untreated grs357, untreated
wildtype, fluoxetine treated grs357, and fluoxetine treated wild-
type. All were siblings from the same clutch. The data were
analyzed using repeated measures ANOVAs with trial or block
number as the within subjects factors and genotype or drug treat-
ment as the between subjects factors. Movement distance and
latency measurements were done by an automated motion track-
ing computer program, custom written in MySQL for this study.
Group response rate, defined as the percentage of each group that
met a minimum response criteria of>1mm of movement within
500ms post-stimulus, was calculated for each trial. Startle habit-
uation was measured as the statistical effect of trial number, for
short-term habituation, or block number, for longer term habit-
uation. Data for a larva was included in the analysis only if the
larva met the response criteria (>1mmmovement within 500ms
post-stimulus) on the first trial of the first block. This resulted
in removal of 7 larvae each from the untreated grs357 and wild-
type groups, and 10 larvae each from the two fluoxetine treated
groups.
WHOLE-BODY CORTISOL ASSAY
After behavioral recordings the larvae were collected by group,
euthanized by overexposure to an anesthetic solution (10min
bath application of 0.1% Tricaine methanesulfonate (Sigma),
pH’d to 7.0), and then homogenized with a rounded glass rod
inside 1.5ml Eppendorf tubes. Tubes were spun for 5min in a
microfuge and 50μl of supernatant was taken for the ELISA assay.
Cortisol was measured with a human salivary cortisol ELISA kit
(Salimetrics kit 1-3002), following a procedure reported for whole
body cortisol measurement in adult zebrafish (Egan et al., 2009).
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Twenty-four larvae from each group (the same larvae used
in behavioral experiments that tested fluoxetine effects) were
homogenized together on day 7 post-fertilization in equal vol-
umes of phosphate-buffered saline (PBS) and then split into
duplicate samples for testing. The absorbance values obtained
were then averaged across the two duplicate samples for each
group. Individual larvae could not be tested because of their small
size, so inferential statistical tests on cortisol measurements were
not feasible.
POMC in situ hybridization
The pro-opiomelanocortin (pomc) antisense probe was obtained
from Deborah Kurrasch (UC Alberta, Calgary). ISH was per-
formed in 5 day old larvae according to a previously reported
protocol (Kurrasch et al., 2009). Larvae were fixed in 4%
paraformaldehyde in PBS at 4◦C for 12 h then stored in 100%
methanol at −20◦C. Larvae were rehydrated in PBS-Tween
(PBS; 0.1% Tween-20), incubated in proteinase K (20μg/ml;
8min), refixed in 4% paraformaldehyde for 20min, prehy-
bridized (65–70◦C; 1 h), and hybridized (65–70◦C, overnight)
with the pomc probe. Embryos were washed, blocked in 5% sheep
serum, incubated in α-digoxigenin (DIG) antibody overnight
at 4◦C, washed, and incubated with p-nitroblue tetrazolium
chloride/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP) in
staining buffer (100mMNaCl, 50mMMgCl2, 100mMTris-HCl,
0.1% Tween-20). The reaction was stopped after approximately
3 h by rinsing with PBSTw, and larvae were then placed in 90%
glycerol for clearing.
DATA ANALYSIS
Videos of larval movements were quantified using ImageJ
(Abramoff et al., 2004). Each video frame was subtracted from
a reference image that contained no larvae but was otherwise
identical, generating a new video in which only the larvae are
visible. The position of each larva on each frame was mea-
sured as the XY coordinates of the center of mass the larva’s
image on each frame. XY coordinates were then imported into
a MySQL database (Oracle) for further processing. To distin-
guish the activity pattern of each larva, coordinate pairs were
sorted by the area occupied by each well within the 96-well
image. Another script in the database program calculated the dis-
tance traveled for each larva, latency of movement onset, and
percentage of time in motion per hour and overall. Processed
data were exported to PASW to conduct inferential statistical
tests. Circadian activity rhythm was analyzed using a repeated
measures ANOVA with time (ZT) as the within subjects factor
and genotype as the between subjects factors. Startle responses
were also analyzed with repeated measures ANOVA, with trial
or block number as the within subjects factor, and genotype
as the between subjects factor. The effects of Fluoxetine treat-
ment were examined for each genotype in separate analyses.
T-tests were used to measure group differences in overall
spontaneous activity, startle response rate, and pigmentation. The
Greenhouse-Geisser correction against unequal variances was
applied in every analysis, and reported degrees of freedom were
rounded to the nearest whole number. Effect sizes were always
reported.
RESULTS
MUTANT LARVAE CAN BE SORTED BY VBA
Clutches from heterozygous mutant parents were consistently
sortable on the basis of the VBA test on day 5 post-fertilization.
The VBA defect is a reliable phenotypic marker of the homozy-
gous mutant genotype (Ziv et al., 2012). Analysis of two separate
clutches from the same identified heterozygous parents showed
the expected ratio (1:4) of VBA− and VBA+ larvae. Of 194 lar-
vae, 47 were manually sorted into the dark pigmentation group
(VBA−, presumed mutants) and 147 into the light pigmentation
group (VBA+), which is consistent with the predicted frequency
distribution [χ2
(1, N = 194) = 0.06, p = 0.80]. Skin darkness on
the dorsal surface of the body was also significantly different
between the manually sorted VBA− and VBA+ groups [aver-
age 8-bit gray scale value = 82.91 ± 13.31 and 61.45 ± 10.04
for VBA+ and VBA− groups, respectively; t(65) = 7.459, p <
0.001, d = 1.82]. Figure 2 shows photographs of a representa-
tive larva from each group, taken immediately after VBA stimulus
presentation.
PHYSIOLOGICAL STRESS MARKERS ARE MISREGULATED IN grs357
MUTANT LARVAE
Whole body cortisol was measured in 4 groups: grs357 mutants
and wildtype, with and without fluoxetine treatment. Untreated
mutants had the highest levels of whole body cortisol (6.07 ±
0.03mg/ml), approximately 50% greater than that measured for
untreated wildtype larvae (4.02 ± 0.03mg/ml). In both mutants
and controls, fluoxetine treatment was associated with slightly
lower cortisol levels (Figure 3).
Expression of pomc RNA was strongest in the region of the
pituitary in all 25 larvae examined. The area of the brain showing
pomc reactivity was consistently larger in grs357 than in wildtype
larvae. Betamethasone 17-valerate, a synthetic glucocorticoid,
suppressed pomc transcript in wildtype larvae as expected, but
FIGURE 3 | Whole body cortisol measurements in 7 day old zebrafish
larvae. Cortisol measurements in 7 day old grs357 mutants and wildtype
siblings with and without fluoxetine treatment. Each group consisted of 24
larvae processed together, split into two duplicate samples, and tested
concurrently. Values shown are transformed from ELISA absorbance
measurements. Error bars are SEMs of the two duplicate samples per
group.
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FIGURE 4 | RNA in situ hybridization for pomc transcript in 5 day old
larvae. Results are presented from a 2 × 2 experimental design testing
the effects of genotype (rows) and betamethasone 17-valerate treatment
(columns) on pomc expression. Two representative larvae per group
are shown (N = 5 per group). pomc reactivity is localized to the pituitary
region in all groups, but in grs357 larvae expression appeared stronger
and showed no suppression after treatment with betamethasone
17-valerate.
did not appear to suppress pomc in grs357 larvae. Figure 4 shows
pomc labeling in two larvae from each group (N = 5 per group).
Labeling was absent in a control group in which the pomc sense
probe was used (not shown).
grs357 MUTANT SPONTANEOUS LOCOMOTOR ACTIVITY IS
DEPRESSED, BUT RESTORED BY FLUOXETINE
In both spontaneous activity experiments, untreated grs357 larvae
had significantly lower spontaneous swimming activity than wild-
type controls (Figure 5). Average percent of time spent in motion
across the 24 h observation was 7.0 ± 1.7% formutants and 9.5 ±
3.3% for controls [F(1, 65) = 5.21, p = 0.026, η2p = 0.07], and
across the 8 h observation activity values were 3.95 ± 2.2% and
21.2 ± 18.7% for untreated mutants and siblings, respectively
[t(30) = 3.7, p = 0.001, d = 1.30]. Despite lower activity levels,
grs357 showed evidence of a circadian activity rhythm with the
same phase as the wildtype group, with peak activity occurring
at ZT 13 h (Figures 5A,B).
There were significant effects of fluoxetine treatment on spon-
taneous activity in the 8 h observation [F(3, 60) = 7.3, p < 0.001,
η2p = 0.21]. Spontaneous activity was lowest in untreated grs357
larvae (3.96 ± 2.2%), and was significantly different from activ-
ity levels in wildtype controls [21.2 ± 18.7%; t(15, 41) = 3.7, p =
0.002, d = 1.30] and in fluoxetine treated mutants [15.4 ± 4.9%;
t(20, 67) = 8.5, p < 0.001, d = 3.01]. Fluoxetine had no effect on
spontaneous activity among wildtype larvae [t(30) = 0.27, p =
0.79, d = 0.09; Figure 5C].
grs357 MUTANT STARTLE RESPONSES ARE INCREASED, BUT
NORMALIZED BY FLUOXETINE
The grs357 group had significantly elevated startle responses
(Figure 6). As a group, mutants had larger startle swims on 20
out of 25 trials. Average distance traveled in the 1 s following
the startle stimulus was 2.3 ± 2.5mm for mutants compared to
1.5 ± 2.2mm for controls [F(1, 32) = 6.05, p = 0.02, η2p = 0.16].
There were significant main effects of trial number [F(2, 75) =
22.0, p < 0.001, η2p = 0.41] and block number [F(3, 110) = 5.2,
p = 0.001, η2p = 0.14], reflecting declining response magnitudes
across trials and blocks (i.e., habituation). There were no signif-
icant interaction effects with genotype, implying no differences
in habituation between mutants and controls. However, because
grs357 had larger responses on the first two trials of each block, the
overall rate of habituation within blocks was numerically greater
for grs357 than for wildtype controls (Figures 6A,C).
Fluoxetine treatment resulted in significantly smaller star-
tle responses in mutants [F(1, 29) = 10.2, p = 0.003, η2p = 0.26;
Figures 6B,D] but had no effect in wildtype controls [F(1, 29) =
0.4, p = 0.517, η2p = 0.015; data not shown]. There were
significant main effects of trial and block in mutants [F(2, 67) =
198.5, p < 0.001, η2p = 0.40 for trials, F(3, 95) = 13.05, p < 0.001,
η2p = 0.31 for blocks] and in wildtype controls [F(3, 85 = 8.9,
p < 0.001, η2p = 0.23 for trials, F(3, 97) = 18.1, p < 0.001, η2p =
0.38 for blocks], but no interaction effects between fluoxe-
tine and trials or blocks. Therefore, fluoxetine did not alter
the dynamics of habituation with repeated elicitation of startle
(Figure 6B). Response rate was higher among untreated mutants
versus wildtype controls in 22 out of the 25 trials run. The per-
cent of the group responding across all 25 trials was 62.1 ±
17.7% for untreated grs357 larvae compared to 43.1 ± 19.0% for
untreated controls, and this difference was significant [t(48) =
3.66, p = 0.001, d = 1.03; Figure 6D]. Untreated mutants also
had significantly higher response rate than fluoxetine treated
mutants [t(48) = 4.65, p < 0.001, d = 1.32], but fluoxetine did
not affect startle response rate in wildtype larvae.
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FIGURE 5 | Spontaneous activity in grs357 and wildtype larvae. (A)
Average hourly activity (±standard error) across a 24 h spontaneous activity
recording (N = 48 per group). Both groups showed a circadian activity rhythm
with a peak at ZT13, but wildtype larvae had a higher overall activity level.
(B) Activity as a function of subjective light cycle phase. Both groups had
significantly higher activity during the subjective light phase. (C) Fluoxetine
effects on spontaneous swimming activity (N = 24 per group). Fluoxetine
increased activity in grs357 but had no effect in the wildtype group. ∗P < 0.5.
DISCUSSION
Physiological and behavioral indices of stress were both found to
be elevated in grs357 mutant zebrafish larvae possessing a non-
functional GR. The hyper-stress phenotype of grs357 likely results
from the loss of negative feedback to brain stress circuits that is
normally mediated by glucocorticoid signaling in the hypotha-
lamus (Figure 1). The failure of grs357 mutant larvae to respond
to treatment with betamethasone (a synthetic glucocorticoid) by
inhibiting pomc expression, as wildtype larvae did, is the most
direct evidence presented here that negative feedback is miss-
ing in the mutant. Increased baseline levels of pituitary pomc
and whole body cortisol also support this mechanism. These
effects on physiological stress markers in grs357 larvae are quite
similar to those seen in the adult mutants (Ziv et al., 2012)
and are remarkable given the young age of the fish. Sequence
analysis localized the mutation to a critical GR DNA binding
region in the second zinc finger domain and transcriptional assays
found the mutant receptor completely unable to mediate gene
regulatory responses to exogenous cortisol (Ziv et al., 2012). The
VBA-deficient phenotype of the mutant, which led to its original
discovery (Muto et al., 2005) might be related to an upregulation
of alpha-melanocyte stimulating hormone, which is encoded by
the POMC precursor. The failure to concentrate melanin pigment
is thus consistent with a lack of GR-mediated negative feedback
on pomc expression.
The grs357 mutant larvae had larger behavioral startle
responses than wildtype despite having lower levels of spon-
taneous locomotor activity. Therefore, the startle analysis
may underestimate the difference between mutants and wild-
type larvae; startle measurements did not account for baseline
activity levels, and mutants exhibited a greater baseline-to-startle
activity difference. This result also suggests that the sponta-
neous activity deficit in mutants is not due to an inability to
move as quickly as wildtype larvae. Lower spontaneous activity
in the mutant was observed in two separate experiments pre-
sented here, both of which extend a previous, semi-quantitative
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FIGURE 6 | Startle responses in wildtype (N = 17), untreated
grs357 (N = 17), and fluoxetine treated grs357 larvae (N = 14).
(A) A comparison of startle magnitude (±SEM) in untreated wildtype and
grs357 larvae. Mutants had significantly larger responses than wildtype across
all trials. Habituation was evident both within blocks and across blocks.
(B) A comparison of startle magnitude in mutant larvae with and without
fluoxetine treatment. Fluoxetine resulted in significantly lower startle
responses inmutants, but the groups did not differ on measures of habituation.
(C) Habituation within block shown as the slope of the regression line through
the 5 trails on each block, and as an average of all 25 startle trials. Mutants had
steeper habituation slopes (more habituation) in 4 out of 5 blocks, and across
all 25 trials, reflecting the larger startle responses of mutants on the earliest
trials of each block. This graph illustrates a trend in the data, but effect of
genotype on habituation was not statistically significant. (D) Percent of group
responding across all 25 trials. Untreated mutants responded significantly more
frequently than wildtype groups or fluoxetine treated mutants (∗P < 0.05).
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finding (Muto et al., 2005). Zebrafish are known to freeze under
certain stress conditions, including being placed in novel envi-
ronments (Egan et al., 2009). Lower spontaneous activity in grs357
may therefore be a behavioral expression of stress deriving from
internal physiology.
Although the differences in startle and spontaneous activ-
ity between grs357 and wildtype larvae were statistically signif-
icant, they were moderate in size. The fact the grs357 zebrafish
are adult-viable also implies constraints on the severity of their
behavioral impairments as larvae, since very severe impair-
ments would be lethal. Considering the many genes, physiolog-
ical systems, and developmental processes that are influenced
by glucocorticoid signaling, it seems surprising that GR knock-
out in zebrafish does not result in a more extreme behavioral
phenotype. However, this result is consistent with reports on
targeted GR gene knockout mice. In one study, GR knock-
out mice that survived to adulthood were behaviorally normal
despite elevated levels of adrenocorticotropic hormone (ACTH)
and cortisol (Oitzl et al., 1997). In another study, GR knock-
out in the forebrain in mice caused moderate depression-
like symptoms in the open field and elevated plus maze tests
(Wei et al., 2004). One reason that stress behavior may be
only moderately increased by loss of GR signaling in grs357 is
that behavioral responses to corticosteroids are partly medi-
ated by mineralocorticoid receptors. In mice, mineralocorticoid
receptors help mediate stress effects on locomotor behavior,
aggression, and memory formation (Groeneweg et al., 2011).
Mineralocorticoid receptors are presumed to functional normally
in grs357 larvae and are expressed at normal levels (Ziv et al.,
2012).
Another reason that the health and behavior deficits of grs357
mutants are not more severe may be that some GR function is
preserved in spite of the total loss of DNA binding and tran-
scriptional effects. Activated GRs are known to interact directly
with several enzymes and proteins, including other transcription
factors, indicating a diversity of glucocorticoid signaling mecha-
nisms (Revollo and Cidlowski, 2009). These non-transcriptional
effects of the GR include interactions with proteins such asMAPK
that are known to be involved in the regulation of behavioral
stress responses (Gutièrrez-Mecinas et al., 2011). It is espe-
cially of interest to know whether fluoxetine’s effects on grs357
mutant behavior in this study, including normalization of spon-
taneous activity levels and startle responses, are mediated by
non-transcriptional effects of the GR. Furthermore, any changes
in the expression levels of the GR due to a loss of its transcrip-
tional activity could modify these non-transcriptional actions.
Since the grs357 mutation selectively disrupts the DNA-binding
domain of the GR protein (Ziv et al., 2012), it is possible that some
or all of the GR protein-protein interactions are intact, but studies
that directly examine the targets of those interactions in mutant
zebrafish are required to confirm that possibility.
Interactions between glucocorticoid and serotonin signaling
are strongly implicated in human stress disorders, both in their
pathogenesis and treatment (Anacker et al., 2011). One current
hypothesis is that the therapeutic effects of serotonergic antide-
pressants depend on the drugs’ ability to decrease HPA activity
and restore normal HPA responsiveness (as measured by the
dexamethasone suppression test; Knorr et al., 2009). Fluoxetine
had opposing effects in grs357 mutants, increasing spontaneous
activity but decreasing startle activity. In both cases, however,
fluoxetine treatment brought mutant performance closer to wild-
type values. This “normalizing” effect of fluoxetine in grs357
mutants may resemble therapeutic effects in humans, but the
mechanisms are likely to be different.
In humans, SSRI’s are proposed to upregulate GR expres-
sion, thereby facilitating negative feedback effects of cortisol in
the brain (Anacker et al., 2011). In contrast, upregulation of
a non-functional GR in grs357 should not produce any effect.
One explanation may be that fluoxetine also influences miner-
alocorticoid signaling in grs357, with effects on the brain and
behavior (Hlavacova et al., 2010). Fluoxetine had no effects on
wildtype behavior in the present study. A previous study that
found the same concentration and timing of fluoxetine exposure
in zebrafish larvae did depress spontaneous activity, though it had
no effect on heart rate or pectoral fin movements (Airhart et al.,
2007). This discrepancy may result from the different methods
used to measure spontaneous activity.
GR mutation occurs rarely in humans, and can result in
a syndrome known as primary glucocorticoid resistance (Ruiz
et al., 2001; Bouligand et al., 2010). Patients may be asymp-
tomatic or affected with conditions including fatigue, hyperten-
sion, and hirsutism (Trebble et al., 2010). Since these are all
heterozygous GR mutations, the range of symptoms may relate
to different mutations and degrees of haploinsufficiency. Two
consistent findings in glucocorticoid resistance in humans are
elevated stress hormones and an impaired dexamethasone sup-
pression test, both of which imply a loss of GR-mediated negative
feedback in the brain (Kolber et al., 2008; van Rossum and
van den Akker, 2011). Interestingly, glucocorticoid resistance in
humans, whether caused by GR mutation or other mechanisms,
is not consistently associated with depression or anxiety, while
GR hypersensitivity is associated with depression (Anacker et al.,
2011).
Zebrafish larvae are increasingly seen as a useful model in
which to study principles of stress and stress-related disorders.
Homologies between human and zebrafish systems include not
only physiological mechanisms but also adaptive functions. For
example, both humans (Heinrichs et al., 2003) and zebrafish
(Filby et al., 2010) show HPA axis response to social stressors,
and social buffering of stress (Ziv et al., 2012). The current study
completes this picture by showing that behavioral effects of HPA
dysregulation and their reversal with known antidepressants can
already be detected at larval stages. The grs357 mutant zebrafish
may therefore prove useful for evaluating the effect of chronic
stress on brain circuitry and also as a convenient model for in vivo
drug screens in search of novel therapeutic agents.
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